Work

Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia

Year: 2023

Type: article

Abstract: We report a patient with catastrophic antiphospholipid syndrome who had significant improvement after corticosteroids, plasmapheresis, argatroban, rituximab, and sirolimus. Argatroban was used instead of heparin due to a history of heparin-induced thrombocytopenia.

Source: Case Reports in Rheumatology

DOI: 10.1155/2023/3226278

Authors: Haytham Hasan, Ivana Surjancev, Jon A. Arnason, Shivani Garg, William Nicholas Rose

Institutions: University of Wisconsin–Madison, UW Health University Hospital

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $725